Treatment of Steroid and Cyclosporine-Resistant Idiopathic Nephrotic Syndrome in Children

Steroid-resistant nephrotic syndrome (SRNS) in children carries a significant risk of progression to end-stage renal failure (ESRF). We report a two-step protocol adapted in children with SRNS. Thirty-seven SRNS were treated with cyclosporine A (CyA) in association with prednisolone (alternate day) for 6 months (first-step treatment). Twelve patients (32.4%) went into complete remission, and 2 (5.4%) got partial remission. The other 23 cases who were steroid and CyA resistant entered a second-step treatment with withdrawing steroids, with CyA (5 mg/kg/day) in association with mycophenolate mofetil (MMF) 30 mg/kg/day for 6 months. Complete remission was observed in 11 cases (47.82%) and partial remission in 2 cases (8.7%). After two steps of treatment, 27/37 children went into total remission. In steroid and CyA-resistant INS, the association of MMF with CyA was able to induce remission in about half cases without relevant side effects.

[1]  J. Kari,et al.  Treatment of steroid resistant nephrotic syndrome in children. , 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[2]  Jin He,et al.  Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome , 2010, Pediatric Nephrology.

[3]  Elsevier Sdol,et al.  Current Problems in Pediatric and Adolescent Health Care , 2009 .

[4]  W. Hop,et al.  Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome , 2008, Pediatric Nephrology.

[5]  R. Coppo.  Non-steroidal and non-cytotoxic therapies for nephrotic syndrome. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  M. del Río,et al.  Evaluation and management of steroid-unresponsive nephrotic syndrome , 2008, Current opinion in pediatrics.

[7]  J. Ehrich,et al.  Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  D. Gipson,et al.  Therapeutic approach to FSGS in children , 2007, Pediatric Nephrology.

[9]  J. Craig,et al.  Non-corticosteroid treatment for nephrotic syndrome in children. , 2008, The Cochrane database of systematic reviews.

[10]  O. Berbel,et al.  Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome , 2005, Pediatric Nephrology.

[11]  G. Rasool,et al.  Histopathological diagnosis and outcome of paediatric nephrotic syndrome. , 2004, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[12]  A. Bakkaloğlu,et al.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[13]  G. Filler,et al.  Is there really an increase in non-minimal change nephrotic syndrome in children? , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  J. Craig,et al.  Interventions for steroid-resistant nephrotic syndrome: a systematic review , 2003, Pediatric Nephrology.

[15]  J. Bonnet,et al.  Mycophenolic acid antagonizes the activation of cultured human mesangial cells. , 2002, Kidney international.

[16]  J. Majó,et al.  Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  D. Kershaw,et al.  Pediatric steroid-resistant nephrotic syndrome. , 2001, Current problems in pediatric and adolescent health care.

[18]  A. Al-Uzri,et al.  Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome , 2001, Pediatric Nephrology.

[19]  T. Yan,et al.  [Integrated traditional Chinese and Western medicine]. , 2001, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

[20]  R. Portman,et al.  Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. , 1999, Kidney international.

[21]  S. Hulton,et al.  Vincristine and focal segmental sclerosis: do we need a multicentre trial? , 1998, Pediatric Nephrology.

[22]  R. Sibley,et al.  Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. , 1995, Clinical nephrology.

[23]  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. , 1981, The Journal of pediatrics.